Physician profile
Russell M Canham
NPI 1629288246
$183,611.16
in general payments reported to CMS, 2019-2025
27 companies · $8,297 in 2025
The $8,297 reported for 2025 was more than what 76% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $28K · 2021: $9,242 · 2022: $33K · 2023: $6,376 · 2024: $72K · 2025: $8,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $8,115 · Food and Beverage: $5,640 · Consulting Fee: $4,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $37,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,181.00 |
| Travel and Lodging | $8,115.21 |
| Food and Beverage | $5,640.13 |
| Consulting Fee | $4,843.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $105,069.91 | 2019-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $43,232.44 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11,874.45 | 2019-2025 | Lifevest |
| Abbott Laboratories | $10,325.59 | 2019-2025 | Accent, Jot Dx, Assurity |
| Amarin Pharma, INC. | $8,833.68 | 2019-2022 | |
| Medtronic Vascular, INC. | $902.18 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $667.32 | 2021-2025 | Verquvo |
| Medtronic, INC. | $452.10 | 2021-2025 | Linq II, Micra |
| Amgen INC. | $449.78 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $316.82 | 2019-2025 | |
| Boston Scientific Corporation | $299.93 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Watchman Flx |
| Astrazeneca Pharmaceuticals Lp | $248.05 | 2020-2025 | Farxiga |
| Pfizer INC. | $225.88 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.18 | 2020-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $93.96 | 2019-2023 | Camzyos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $86.05 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $85.65 | 2024-2025 | Assure Wcd |
| Itamar Medical INC | $83.10 | 2021 | |
| Inspire Medical Systems, INC. | $63.20 | 2023-2025 | Inspire |
| Edwards Lifesciences Corporation | $42.88 | 2022 | |
| Baxter Healthcare | $32.61 | 2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $27.01 | 2023-2024 | |
| Heartflow, INC. | $23.64 | 2022 | |
| Bardy Diagnostics, INC. | $20.00 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $13.50 | 2024 | Rhythm Express |
| Elutia, INC. | $11.15 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Canham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.